Q1. What is the business of Paras Healthcare?

Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.

Q2. Why is the company raising funds via IPO?

The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.

Q3. What is the size of the issue and where will it list?

The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale; shares will list on BSE and NSE.

Q5. What are the potential upsides?

Upsides include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.

Q6. How to apply for the IPO?

Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.

Paras Healthcare IPO: Price, Review, Detail, Analysis, IPO Score

Closed

Paras Healthcare IPO: Price, Review, Detail, Analysis, IPO Score

Market Cap

₹ 7,498 Crore

IPO Issue Size

₹ 1,450 Crores

Expected Price by IPOCorner

₹ 660 – ₹ 693

IPO Score

*Score varies on actual price

Paras Healthcare operates a network of multi-specialty tertiary hospitals across North and East India, focusing on making advanced medical care accessible and affordable.
The company’s IPO aims to raise approximately ₹ 1,450 Crore which includes a Fresh issue of ₹ 500 Crores along with an offer-for-sale of ₹ 950 Crores, providing investors an opportunity to participate in India’s growing healthcare sector.

Paras Healthcare was incorporated on December 21, 1987 & currently Dr. Dharminder Kumar Nagar acts as the Managing Director of the company, who has spearheaded the company’s expansion since its inception.

Paras Healthcare Limited delivers specialised tertiary medical care services – covering cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and joint replacement – primarily in underserved Tier-II and Tier-III cities.
Subscription date to apply for Paras Healthcare starts on 21st Oct’26 & Closes on 23rd Oct’26. Price band for the IPO is ₹660 to ₹693 with a lot size of 21 Shares.

Year	2024
Networth	~ ₹ 338.50 Cr
Revenue	~ ₹ 1129.03 Cr
EBITDA	~ ₹ 154.41 Cr
PAT	~ ₹ -15.33 Cr
EBITDA Margin	~ 13.68%
PAT Margin	-1.36%
Face Value	Rs.01 per Equity Share

IPO Important Dates

#	Date
Open Date	21-Oct'26
Close Date	23-Oct'26
Anchor Investor Bidding	20-Oct'26
Allotment Date	26-Oct'26
Refunds& Demat Credit	27-Oct'26
Tentative Listing Date	26-Oct'26

Use Of Proceeds

Purpose	Amount
Prepayment or re-payment of Borrowing	₹ 320.9 Cr




Investment in our Subsidiary	₹ 54.1 Cr

Financial Data

#	2022	2023	2024
Revenue (₹ Cr)	₹ 779.9	₹ 917.9	₹ 1,129.0
PAT (₹ Cr)	₹ -14.8	₹ -42.8	₹ -15.3
Asset (₹ Cr)	₹ 963.5	₹ 1,293.1	₹ 1,477.7
Net Worth (₹ Cr)	₹ 73.1	₹ 30.1	₹ 338.5

IPO Grey Market Premium

Date	IPO Price	IPO GMP	Profit Per Lot
23-Oct	₹ 660 - ₹ 693	₹ 07	₹ 147
22-Oct	₹ 660 - ₹ 693	₹ 20	₹ 420
21-Oct	₹ 660 - ₹ 693	₹ 80	₹ 1,680
20-Oct	₹ 660 - ₹ 693	₹ 92	₹ 1,932
19-Oct	₹ 660 - ₹ 693	₹ 96	₹ 2,016

Pros

Strong presence in North & East India with growing hospital network.
Focus on underserved Tier-II & Tier-III cities.
Consistent revenue growth and improving margins.
Expansion in high-demand healthcare segments.
Experienced management with proven operational track record.

Cons

Loss-making company with negative PAT.
High competition from established hospital chains.
Rising operational and finance costs.
Heavy dependence on a few key hospitals.
Regulatory and compliance risks in healthcare sector.

Promoters – Pre offer equity (Approx)

Promoters	% Shares
Dr. Dharminder Kumar Nagar	~75.32%
Commelina Ltd.	~24.68%
-	-
-	-
-	-
-	-

Lot Size details

Application Type	Lot Size	No. of Lot	No. of Shares	Investment Amount
Retail (Min)	21 Shares	1	21 Shares	₹ 13,860
Retail (Max)	21 Shares	13	273 Shares	₹ 1,89,189
HNI (Min)	21 Shares	14	294 Shares	₹ 1,94,040
HNI (Max)	21 Shares	66	1,386 Shares	₹ 9,60,498
Big HNI (Min)	21 Shares	67	1,407 Shares	₹ 9,28,620

Key Performance Index (KPI)

ROE	12.98%
ROCE	10.76%
RoNW	12.98%

Lead / Book Running Lead Managers

ICICI Securities Limited, IIFL Securities Limited, Motilal Oswal Investment Advisors Limited

Registrar (RTA)

Link Intime India Private Limited

Q1. What is the business of Paras Healthcare?
Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.
Q2. Why is the company raising funds via IPO?
The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.
Q3. What is the size of the issue and where will it list?
The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale; shares will list on BSE and NSE.
Q5. What are the potential upsides?
Upsides include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.
Q6. How to apply for the IPO?
Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.